Long-term control and safety of larotrectinib in a cohort of adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumors Meeting Abstract
| Authors: | Perreault, S.; Drilon, A. E.; Lassen, U. N.; Geoerger, B.; Nysom, K.; Øra, I.; Gavrilovic, I. T.; Norenberg, R.; Fellous, M. M.; De la Cuesta, E. A.; Laetsch, T. W.; Doz, F.; van Tilburg, C. M. |
| Abstract Title: | Long-term control and safety of larotrectinib in a cohort of adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumors |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680300661 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.2010 |
| Notes: | Meeting Abstract: 2010 -- Meeting also held virtually -- Source: Wos |
